The combination therapy of PEM, platinum, and ICIs has been proposed as the first-line standard regimen for the treatment of advanced lung adenocarcinoma, irrespective of tumor PD-L1 expression [6]. This evidence concerns the gene CD274 and lung adenocarcinoma.